Logo image of CIM

CHIMERA INVESTMENT CORP (CIM) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CIM - US16934Q8024 - REIT

12.88 USD
-0.02 (-0.16%)
Last: 12/26/2025, 8:04:00 PM
12.8228 USD
-0.06 (-0.44%)
After Hours: 12/26/2025, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, CIM scores 3 out of 10 in our fundamental rating. CIM was compared to 68 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. CIM has a bad profitability rating. Also its financial health evaluation is rather negative. CIM scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CIM had positive earnings in the past year.
In the past year CIM has reported a negative cash flow from operations.
CIM had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CIM had a positive operating cash flow.
CIM Yearly Net Income VS EBIT VS OCF VS FCFCIM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

The Return On Assets of CIM (-0.20%) is worse than 66.18% of its industry peers.
With a Return On Equity value of -1.18%, CIM is not doing good in the industry: 66.18% of the companies in the same industry are doing better.
CIM's Return On Invested Capital of 0.83% is fine compared to the rest of the industry. CIM outperforms 75.00% of its industry peers.
CIM had an Average Return On Invested Capital over the past 3 years of 1.06%. This is in line with the industry average of 1.28%.
Industry RankSector Rank
ROA -0.2%
ROE -1.18%
ROIC 0.83%
ROA(3y)-1.1%
ROA(5y)0.13%
ROE(3y)-5.46%
ROE(5y)0%
ROIC(3y)1.06%
ROIC(5y)1.7%
CIM Yearly ROA, ROE, ROICCIM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

CIM's Profit Margin has declined in the last couple of years.
CIM has a better Operating Margin (18.08%) than 72.06% of its industry peers.
CIM's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 33.41%, CIM is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
CIM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 18.08%
PM (TTM) N/A
GM 33.41%
OM growth 3Y-27.82%
OM growth 5Y-11.26%
PM growth 3Y-41.81%
PM growth 5Y-13.49%
GM growth 3Y-21.29%
GM growth 5Y-6.24%
CIM Yearly Profit, Operating, Gross MarginsCIM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

CIM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CIM has been increased compared to 1 year ago.
The number of shares outstanding for CIM has been increased compared to 5 years ago.
The debt/assets ratio for CIM has been reduced compared to a year ago.
CIM Yearly Shares OutstandingCIM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CIM Yearly Total Debt VS Total AssetsCIM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

Based on the Altman-Z score of -0.50, we must say that CIM is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.50, CIM is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
A Debt/Equity ratio of 4.27 is on the high side and indicates that CIM has dependencies on debt financing.
CIM's Debt to Equity ratio of 4.27 is in line compared to the rest of the industry. CIM outperforms 58.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.27
Debt/FCF N/A
Altman-Z -0.5
ROIC/WACC0.17
WACC4.91%
CIM Yearly LT Debt VS Equity VS FCFCIM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

CIM has a Current Ratio of 0.12. This is a bad value and indicates that CIM is not financially healthy enough and could expect problems in meeting its short term obligations.
CIM has a Current ratio of 0.12. This is comparable to the rest of the industry: CIM outperforms 41.18% of its industry peers.
A Quick Ratio of 0.12 indicates that CIM may have some problems paying its short term obligations.
The Quick ratio of CIM (0.12) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
CIM Yearly Current Assets VS Current LiabilitesCIM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.05% over the past year.
The earnings per share for CIM have been decreasing by -26.31% on average. This is quite bad
The Revenue has been growing slightly by 5.28% in the past year.
CIM shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.37% yearly.
EPS 1Y (TTM)4.05%
EPS 3Y-35.1%
EPS 5Y-26.31%
EPS Q2Q%2.78%
Revenue 1Y (TTM)5.28%
Revenue growth 3Y-8.39%
Revenue growth 5Y-11.37%
Sales Q2Q%-2.17%

3.2 Future

Based on estimates for the next years, CIM will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.14% on average per year.
CIM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.85% yearly.
EPS Next Y22.62%
EPS Next 2Y20.63%
EPS Next 3Y15.14%
EPS Next 5YN/A
Revenue Next Year7.21%
Revenue Next 2Y14.13%
Revenue Next 3Y8.85%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CIM Yearly Revenue VS EstimatesCIM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CIM Yearly EPS VS EstimatesCIM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.36, the valuation of CIM can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of CIM indicates a rather cheap valuation: CIM is cheaper than 80.88% of the companies listed in the same industry.
CIM is valuated cheaply when we compare the Price/Earnings ratio to 26.92, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 6.06, the valuation of CIM can be described as very cheap.
Based on the Price/Forward Earnings ratio, CIM is valued cheaper than 91.18% of the companies in the same industry.
CIM is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.46, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.36
Fwd PE 6.06
CIM Price Earnings VS Forward Price EarningsCIM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CIM is valued cheaper than 85.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 55.2
CIM Per share dataCIM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CIM's earnings are expected to grow with 15.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y20.63%
EPS Next 3Y15.14%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.10%, CIM is a good candidate for dividend investing.
CIM's Dividend Yield is slightly below the industry average, which is at 10.99.
CIM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
Industry RankSector Rank
Dividend Yield 9.1%

5.2 History

The dividend of CIM decreases each year by -17.33%.
CIM has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-17.33%
Div Incr Years0
Div Non Decr Years0
CIM Yearly Dividends per shareCIM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

5.3 Sustainability

The earnings of CIM are negative and hence is the payout ratio. CIM will probably not be able to sustain this dividend level.
DP-682.63%
EPS Next 2Y20.63%
EPS Next 3Y15.14%
CIM Yearly Income VS Free CF VS DividendCIM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

CHIMERA INVESTMENT CORP

NYSE:CIM (12/26/2025, 8:04:00 PM)

After market: 12.8228 -0.06 (-0.44%)

12.88

-0.02 (-0.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-10 2026-02-10/bmo
Inst Owners55.77%
Inst Owner Change0.06%
Ins Owners1.64%
Ins Owner Change0.19%
Market Cap1.07B
Revenue(TTM)791.98M
Net Income(TTM)-30.31M
Analysts72.5
Price Target14.79 (14.83%)
Short Float %2.97%
Short Ratio3.29
Dividend
Industry RankSector Rank
Dividend Yield 9.1%
Yearly Dividend2.77
Dividend Growth(5Y)-17.33%
DP-682.63%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-30 2025-09-30 (0.37)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.19%
Min EPS beat(2)-20.93%
Max EPS beat(2)-15.44%
EPS beat(4)0
Avg EPS beat(4)-18.38%
Min EPS beat(4)-21.72%
Max EPS beat(4)-15.43%
EPS beat(8)0
Avg EPS beat(8)-20.42%
EPS beat(12)0
Avg EPS beat(12)-24.36%
EPS beat(16)2
Avg EPS beat(16)-17.42%
Revenue beat(2)0
Avg Revenue beat(2)-21.8%
Min Revenue beat(2)-24.11%
Max Revenue beat(2)-19.49%
Revenue beat(4)0
Avg Revenue beat(4)-17.34%
Min Revenue beat(4)-24.11%
Max Revenue beat(4)-9.79%
Revenue beat(8)0
Avg Revenue beat(8)-14.15%
Revenue beat(12)1
Avg Revenue beat(12)-10.59%
Revenue beat(16)5
Avg Revenue beat(16)3.25%
PT rev (1m)-6.45%
PT rev (3m)-6.45%
EPS NQ rev (1m)-0.66%
EPS NQ rev (3m)8.63%
EPS NY rev (1m)-4.53%
EPS NY rev (3m)-2.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.12%
Revenue NY rev (1m)-5.67%
Revenue NY rev (3m)-3.93%
Valuation
Industry RankSector Rank
PE 8.36
Fwd PE 6.06
P/S 1.35
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB 0.42
EV/EBITDA 55.2
EPS(TTM)1.54
EY11.96%
EPS(NY)2.12
Fwd EY16.49%
FCF(TTM)-1.16
FCFYN/A
OCF(TTM)-0.7
OCFYN/A
SpS9.52
BVpS30.92
TBVpS30.92
PEG (NY)0.37
PEG (5Y)N/A
Graham Number32.73
Profitability
Industry RankSector Rank
ROA -0.2%
ROE -1.18%
ROCE 1.65%
ROIC 0.83%
ROICexc 0.87%
ROICexgc 0.88%
OM 18.08%
PM (TTM) N/A
GM 33.41%
FCFM N/A
ROA(3y)-1.1%
ROA(5y)0.13%
ROE(3y)-5.46%
ROE(5y)0%
ROIC(3y)1.06%
ROIC(5y)1.7%
ROICexc(3y)1.07%
ROICexc(5y)1.73%
ROICexgc(3y)1.08%
ROICexgc(5y)1.74%
ROCE(3y)1.76%
ROCE(5y)2.84%
ROICexgc growth 3Y-27.85%
ROICexgc growth 5Y-7.12%
ROICexc growth 3Y-27.99%
ROICexc growth 5Y-7.16%
OM growth 3Y-27.82%
OM growth 5Y-11.26%
PM growth 3Y-41.81%
PM growth 5Y-13.49%
GM growth 3Y-21.29%
GM growth 5Y-6.24%
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 4.27
Debt/FCF N/A
Debt/EBITDA 76.53
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.28
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z -0.5
F-Score3
WACC4.91%
ROIC/WACC0.17
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.05%
EPS 3Y-35.1%
EPS 5Y-26.31%
EPS Q2Q%2.78%
EPS Next Y22.62%
EPS Next 2Y20.63%
EPS Next 3Y15.14%
EPS Next 5YN/A
Revenue 1Y (TTM)5.28%
Revenue growth 3Y-8.39%
Revenue growth 5Y-11.37%
Sales Q2Q%-2.17%
Revenue Next Year7.21%
Revenue Next 2Y14.13%
Revenue Next 3Y8.85%
Revenue Next 5YN/A
EBIT growth 1Y-11.4%
EBIT growth 3Y-33.87%
EBIT growth 5Y-21.34%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-146.25%
FCF growth 3Y-26.56%
FCF growth 5Y25.89%
OCF growth 1Y-127.91%
OCF growth 3Y-26.56%
OCF growth 5Y25.89%

CHIMERA INVESTMENT CORP / CIM FAQ

Can you provide the ChartMill fundamental rating for CHIMERA INVESTMENT CORP?

ChartMill assigns a fundamental rating of 3 / 10 to CIM.


What is the valuation status of CHIMERA INVESTMENT CORP (CIM) stock?

ChartMill assigns a valuation rating of 7 / 10 to CHIMERA INVESTMENT CORP (CIM). This can be considered as Undervalued.


Can you provide the profitability details for CHIMERA INVESTMENT CORP?

CHIMERA INVESTMENT CORP (CIM) has a profitability rating of 3 / 10.


What are the PE and PB ratios of CHIMERA INVESTMENT CORP (CIM) stock?

The Price/Earnings (PE) ratio for CHIMERA INVESTMENT CORP (CIM) is 8.36 and the Price/Book (PB) ratio is 0.42.


What is the financial health of CHIMERA INVESTMENT CORP (CIM) stock?

The financial health rating of CHIMERA INVESTMENT CORP (CIM) is 1 / 10.